Q2 EPS Estimates for Denali Therapeutics Boosted by Wedbush
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Stock analysts at Wedbush lifted their Q2 2025 EPS estimates for Denali Therapeutics in a report released on Wednesday, May 7th. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.76) for the quarter, up from their previous forecast of ($0.77). […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Stock analysts at Wedbush lifted their Q2 2025 EPS estimates for Denali Therapeutics in a report released on Wednesday, May 7th. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.76) for the quarter, up from their previous forecast of ($0.77). […]
